#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital myopathy Squamous cell carcinoma of the vulva Corneal neovascularisation Partial lipodystrophy Vernal keratoconjunctivitis Pulmonary alveolar haemorrhage Primary myelofibrosis Follicle centre lymphoma follicular grade I, II – III Gastrointestinal stromal tumour Prodromal Alzheimer's disease Hairy cell leukaemia Inflammatory myofibroblastic tumour Head and neck cancer Oesophageal adenocarcinoma stage II Synovial sarcoma metastatic More trials…

    Learn about Rare Diseases

    Turner’s syndrome – Trials in Disease Haemolytic uraemic syndrome – Basic Information Myelodysplastic syndrome – Treatment Chondrosarcoma – Trials in Disease Nodal marginal zone B-cell lymphoma – Diagnostics Phenylketonuria – Treatment Osteosarcoma – Life with Disease Waldenstrom’s macroglobulinaemia – Trials in Disease Gaucher’s disease type III – Basic Information Sarcoidosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    AGALSIDASE BETA Etripamil Midomafetamine Hydrochloride Vx-670 Inavolisib Clonazepam Cytisinicline GSKVX000000030810 Specific Nucleic Acid Sna-Xfsc Romosozumab Hydralazine Hydrochloride Exagamglogene Autotemcel Gen1053 Disitamab Vedotin Tenofovir Alafenamide Vutrisiran Interferon Gamma Finasteride Lumasiran Nido-361 More therapies…

    Learn about Your Condition

    Nephropathy Hereditary ataxia Breast cancer IgA nephropathy Optic atrophy B-cell lymphoma recurrent Aicardi-Goutieres syndrome Pemphigus Cancer pain Dyspepsia Mantle cell lymphoma stage IV Glomerulonephritis acute Device related infection Altered state of consciousness Adenomyosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Endometrial cancer

  • Study on Selinexor as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Endometrial cancer metastatic
    • Endometrial cancer
    • Endometrial cancer recurrent
    Investigated Drugs:
    • Selinexor
    Belgium Czechia Germany Greece Italy Spain

  • Study on MK-2870 for Patients with Endometrial Cancer After Platinum and Immunotherapy Treatment

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Caffeine
    • Sacituzumab Tirumotecan
    • Acetylsalicylic Acid
    Austria Belgium Czechia Denmark Finland France +9
Previous Page
1 … 7 8 9

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!